Elon Musk‘s startup Neuralink Corp. should be ready to test its technology on humans in six months, the entrepreneur said Wednesday during a live-streamed update about progress the company has made with its brain-implant technology.
Neuralink has submitted most of its paperwork to the U.S. Food and Drug Administration, which oversees medical devices, including neural implants, Musk said. In 2019, he said the company planned to seek the FDA’s approval for human testing and predicted it could begin as soon as 2020.